---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-188937"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2024-07-30T23:59:59+00:00"
generated_at: "2026-05-31T15:19:00.840745+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# DBV reports Q2 net loss $33.1M, cash $66.2M, going concern doubt; VITESSE on track

## Summary
- Q2 net loss of $33.1M (US GAAP), basic EPS -$0.34 vs -$0.26 in Q2 2023.
- Cash and equivalents $66.2M at June 30, 2024, down from $141.4M at Dec 31, 2023; cash runway extended into Q1 2025.
- Substantial doubt about going concern; expects to need additional capital to fund operations.
- VITESSE Phase 3 enrollment in 4-7-year-olds on track to complete screening by end of Q3 2024.
- Submitted labeling proposal to FDA for COMFORT Toddlers (1-3-year-olds) using EPITOPE data to identify responders.

## SEC filing metadata
- accession: 0001193125-24-188937
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2024-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312524188937/0001193125-24-188937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312524188937/d869824d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-188937
- JSON: https://secwatch.observer/filing/0001193125-24-188937.json
- Plain text: https://secwatch.observer/filing/0001193125-24-188937.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.